Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
American Journal of Clinical Oncology|October 28, 2009
Diagnosis and treatment of malignant pleural effusion: a systematic literature review and new approachesGiuseppe Lombardi, Fable Zustovich, Maria Ornella Nicoletto, et al.
Tumori|June 15, 2007
Lack of cardiotoxicity with liposomal doxorubicin in an elderly case of ovarian cancerMaria Ornella Nicoletto, Martin Donach, Lucia Borgato, et al.
Clinical Chemistry and Laboratory Medicine|September 26, 2012
CA125 reference values change in male and postmenopausal female subjectsGiuseppe Cartei, Francesco Cartei, Martina Bertin, et al.
Cell Death & Disease|July 21, 2017
Autophagy inhibition reduces chemoresistance and tumorigenic potential of human ovarian cancer stem cellsAnna Pagotto, Giorgia Pilotto, Elena Laura Mazzoldi, et al.
Cancer Biology & Therapy|January 22, 2015
Metformin: a modulator of bevacizumab activity in cancer? A case reportStefano Indraccolo, Giovanni Randon, Elisabetta Zulato, et al.
Journal of the Turkish German Gynecological Association|September 25, 2015
Diagnostic and prognostic evaluation of fluorodeoxyglucose positron emission tomography/computed tomography and its correlation with serum cancer antigen-125 (CA125) in a large cohort of ovarian cancer patientsLaura Evangelista, Maurizia Dalla Palma, Michele Gregianin, et al.
Therapeutic Advances in Medical Oncology|June 26, 2023
Oxaliplatin prior to PARP inhibitor in BRCA-mutated ovarian cancerMaria Ornella Nicoletto, Alessandra Baldoni, Francesco Cavallin, et al.
Cancer Chemotherapy and Pharmacology|November 1, 2011
Intrapleural paclitaxel for malignant pleural effusion from ovarian and breast cancer: a phase II study with pharmacokinetic analysisGiuseppe Lombardi, Maria Ornella Nicoletto, Milena Gusella, et al.
Cell Death & Disease|May 30, 2019
A juxtacrine/paracrine loop between C-Kit and stem cell factor promotes cancer stem cell survival in epithelial ovarian cancerElena Laura Mazzoldi, Simona Pavan, Giorgia Pilotto, et al.
Oncology Reports|October 11, 2002
Intralesional topotecan in advanced ovarian cancer: a clinical report, based on a preclinical studyMaria Ornella Nicoletto, Roberto Padrini, Manlio Palumbo, et al.
Pageof 3